NASDAQ:DFFN
Delisted

Diffusion Pharmaceuticals Stock News

etoro logo Buy DFFN
*Your capital is at risk
$5.87
+0 (+0%)
At Close: Nov 28, 2023
Company operations should have been only mildly affected by COVID-19 pandemic. There have recently been further positive developments for the company. Expansion
Inclusion in FDA’s Coronavirus Treatment Acceleration Program significantly shortens regulatory review cycles Simultaneous patient enrollment planned in both the U.S. and.
CEL-SCI’s Pivotal Phase 3 Study has reached the required number of events to evaluate data for Multikine in treatment of Head and Neck Cancer.
There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Amarin (AMRN), Viking Therapeutics (VKTX) and Corvus
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Amarin ( AMRN – Research Report ), Viking Therapeutics ( VKTX – Research Report ) and Corvus Pharma
Under federal regulations, the FDA has up to 60 days to hold an advisory meeting with the Company, but for COVID-19-related submissions, the FDA has announced its intention to significantly shorten 
A sea of pink dazzled residents of Navi Mumbai as thousands of flamingos settled along the creek on Thursday morning. The migratory birds, which visit Mumbai every year, have arrived in huge numbers,
Welcome to our wrap for investors of the key coronavirus news this week. By the numbers Australian deaths: 66, up 47 per cent on last week Australian cases: 6,521, up 8 per cent on last week Global de
The tools, announced on April 3, are part of the Bitcoin SV community's initiative to grow enterprise adoptions and instant transactions.
By David Bautz, PhD NASDAQ:DFFN READ THE FULL DFFN RESEARCH REPORT Business Update Evaluating TSC as Treatment for ARDS On April 1, 2020, Diffusion Pharmaceuticals, Inc. (NASDAQ:DFFN) announced that t
There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Dynavax (DVAX), Crinetics Pharmaceuticals (CRNX) and
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Dynavax (DVAX
CHARLOTTESVILLE, Va., April 01, 2020 -- Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (“Diffusion” or “the Company”), a cutting-edge biotechnology company developing new.
Diffusion Pharmaceuticals Inc (NASDAQ: DFFN) shares were more than doubling Wednesday following an announcement by the company regarding testing of its lead asset for COVID-19-...
The Hyperledger Besu team, today announced Hyperledger’s Technical Steering Committee (TSC) voted to graduate the project from incubation to active
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE